$ALGS

Aligos Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major

PRICE

$1.24 ▼-0.8%

Extented Hours

VOLUME

246,074

DAY RANGE

1.11 - 1.27

52 WEEK

1.03 - 34.31

Join Discuss about ALGS with like-minded investors

Key Metrics

Market Cap

50.81 M

Beta

1.22

Avg. Volume

453.35 K

Shares Outstanding

42.70 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-04

Next Dividend Date

Company Information

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). Aligos’ strategy is to harness the deep expertise and decades of drug development experience its team has in liver disease, particularly viral hepatitis, to rapidly advance its pipeline of potentially best-in-class molecules.

Website:

HQ: ,

Related News